Vuong Trieu

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Neil Desai, Vuong Trieu, Zhiwen Yao et al. · Clinical Cancer Research · 2006 · 1.2K citations

Medicine, Oncology, Pharmacology +14

Gemcitabine Plus<i>nab</i>-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2011 · 1K citations · Full text

Medicine, Oncology, Pharmacology +12

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Alex Sparreboom, Charity D. Scripture, Vuong Trieu et al. · Clinical Cancer Research · 2005 · 496 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients

Neil Desai, Vuong Trieu, B Damascelli et al. · Translational Oncology · 2009 · 395 citations · Full text

Medicine, Cancer Biology, Oncology +8

Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies

David Nyman, Kimberley J. Campbell, Evan M. Hersh et al. · Journal of Clinical Oncology · 2005 · 281 citations · Full text

Medicine, Oncology, Pharmacology +14